{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T21:48:22Z","timestamp":1762033702777,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100014468","name":"Mallinckrodt Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014468","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008680","name":"Mallinckrodt Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008680","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.rmed.2023.107422","type":"journal-article","created":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T01:10:00Z","timestamp":1696986600000},"page":"107422","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Response to Acthar Gel in sarcoidosis uveitis: A prospective open label study"],"prefix":"10.1016","volume":"219","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4817-9404","authenticated-orcid":false,"given":"Patompong","family":"Ungprasert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Careen","family":"Lowder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5769-0717","authenticated-orcid":false,"given":"Sumit","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel L.","family":"Ribeiro Neto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne","family":"Baran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil K.","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel A.","family":"Culver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.rmed.2023.107422_bib1","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1080\/09273948.2017.1386791","article-title":"Clinical characteristics of ocular sarcoidosis: a population-based study 1976-2013","volume":"27","author":"Ungprasert","year":"2019","journal-title":"Ocul. Immunol. Inflamm."},{"issue":"10 Pt 1","key":"10.1016\/j.rmed.2023.107422_bib2","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1164\/ajrccm.164.10.2104046","article-title":"Clinical characteristics of patients in case control study of sarcoidosis","volume":"164","author":"Baughman","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.rmed.2023.107422_bib3","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.ophtha.2015.01.003","article-title":"Sarcoidosis in the national veteran population: association of ocular inflammation and mortality","volume":"122","author":"Birnbaum","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.rmed.2023.107422_bib4","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2147\/OPTH.S128949","article-title":"Management of chronic ocular sarcoidosis: Challenges and solutions","volume":"12","author":"Matsou","year":"2018","journal-title":"Clin. Ophthalmol."},{"issue":"1","key":"10.1016\/j.rmed.2023.107422_bib5","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s41030-022-00181-0","article-title":"Repository corticotropin injection for the treatment of pulmonary sarcoidosis: a narrative review","volume":"8","author":"Baughman","year":"2022","journal-title":"Pulm Ther"},{"key":"10.1016\/j.rmed.2023.107422_bib7","first-page":"19","article-title":"The WASOG Sarcoidosis Organ Assessment Instrument: an update of a previous clinical tool","volume":"31","author":"Judson","year":"2014","journal-title":"Sarcoidosis Diffuse Vasc Lung Dis."},{"key":"10.1016\/j.rmed.2023.107422_bib8","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1136\/thoraxjnl-2012-201962","article-title":"The development and validation of the King's Sarcoidosis Questionnaire for the assessment of health status","volume":"68","author":"Patel","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2023.107422_bib9","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1007\/s12325-022-02176-4","article-title":"Pain and fatigue improvements in patients treated with repository corticotropin injection across five indications: a narrative review","volume":"39","author":"Girman","year":"2022","journal-title":"Adv. Ther."},{"key":"10.1016\/j.rmed.2023.107422_bib10","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1007\/s12325-022-02160-y","article-title":"A narrative review of repository corticotropin injection for the treatment of systemic lupus erythematosus","volume":"39","author":"Askanase","year":"2022","journal-title":"Adv. Ther."},{"issue":"4","key":"10.1016\/j.rmed.2023.107422_bib11","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2217\/nmt-2018-0008","article-title":"Repository corticotropin injection in multiple sclerosis: an update","volume":"8","author":"Kutz","year":"2018","journal-title":"Neurodegener. Dis. Manag."},{"issue":"3","key":"10.1016\/j.rmed.2023.107422_bib12","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00408-017-9994-4","article-title":"Repository corticotropin injection for chronic pulmonary sarcoidosis","volume":"195","author":"Baughman","year":"2017","journal-title":"Lung"},{"key":"10.1016\/j.rmed.2023.107422_bib13","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/aos.14702","article-title":"Management of repository corticotropin injection therapy for non-infectious uveitis: a Delphi study","volume":"99","author":"Nguyen","year":"2021","journal-title":"Acta Ophthalmol."},{"issue":"10","key":"10.1016\/j.rmed.2023.107422_bib14","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2019.12618","article-title":"Effect of corticosteroid-sparing treatment with mycophenolate mofetil vs methotrexate on inflammation in patients with uveitis: a randomized clinical trial","volume":"322","author":"Rathinam","year":"2019","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.rmed.2023.107422_bib15","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ajo.2009.05.008","article-title":"Azathioprine for ocular inflammatory diseases","volume":"148","author":"Pasadhika","year":"2009","journal-title":"Am. J. Ophthalmol."},{"issue":"3","key":"10.1016\/j.rmed.2023.107422_bib16","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ajo.2009.09.026","article-title":"Mycophenolate mofetil for ocular inflammation","volume":"149","author":"Daniel","year":"2010","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.rmed.2023.107422_bib17","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJMoa1509852","article-title":"Adalimumab in patients with active noninfectious uveitis","volume":"375","author":"Jaffe","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rmed.2023.107422_bib18","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1016\/j.ophtha.2006.04.038","article-title":"Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation","volume":"113","author":"Galor","year":"2006","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.rmed.2023.107422_bib19","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1080\/10799893.2020.1818094","article-title":"Distinct binding and signaling activity of Acthar Gel compared to other melanocortin receptor agonists","volume":"41","author":"Huang","year":"2021","journal-title":"J. Recept. Signal Transduct. Res."},{"issue":"4","key":"10.1016\/j.rmed.2023.107422_bib20","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/cpdd.1020","article-title":"Pharmacokinetics and pharmacodynamics of repository corticotropin injection compared with synthetic ACTH1-24 depot and methylprednisolone in healthy subjects","volume":"11","author":"Poola","year":"2022","journal-title":"Clin. Pharmacol. Drug Dev."},{"key":"10.1016\/j.rmed.2023.107422_bib21","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/s13075-015-0823-y","article-title":"Direct effects of HP Acthar Gel on human B lymphocyte activation in vitro","volume":"17","author":"Olsen","year":"2015","journal-title":"Arthritis Res. Ther."},{"issue":"4","key":"10.1016\/j.rmed.2023.107422_bib22","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3109\/08916934.2014.984836","article-title":"Acthar gel treatment suppresses acute exacerbations in murine model of relapsing-remitting multiple sclerosis","volume":"48","author":"Cusick","year":"2015","journal-title":"Autoimmunity"},{"issue":"8","key":"10.1016\/j.rmed.2023.107422_bib23","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1080\/14740338.2020.1779219","article-title":"Safety of repository corticotropin injection as an adjunctive therapy for the treatment of rheumatoid arthritis","volume":"19","author":"Fleischmann","year":"2020","journal-title":"Expet Opin. Drug Saf."},{"issue":"4","key":"10.1016\/j.rmed.2023.107422_bib24","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s40744-020-00236-1","article-title":"Repository corticotropin injection for persistently active systemic lupus erythematosus: results from a phase 4, multicenter, randomized, double-blinded, placebo-controlled trial","volume":"7","author":"Askanase","year":"2020","journal-title":"Rheumatol Ther"},{"issue":"2","key":"10.1016\/j.rmed.2023.107422_bib25","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s40744-020-00199-3","article-title":"Repository corticotropin injection for active rheumatoid arthritis despite aggressive treatment: a randomized controlled withdrawal trial","volume":"7","author":"Fleischmann","year":"2020","journal-title":"Rheumatol Ther"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611123003104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611123003104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T21:42:01Z","timestamp":1762033321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611123003104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":24,"alternative-id":["S0954611123003104"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2023.107422","relation":{},"ISSN":["0954-6111"],"issn-type":[{"type":"print","value":"0954-6111"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Response to Acthar Gel in sarcoidosis uveitis: A prospective open label study","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2023.107422","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107422"}}